AGP Executive Report
Last update: an hour agoDrug Access: Hong Kong approved its 23rd medicine under the “1+” pathway, a treatment for metastatic hormone-sensitive prostate cancer. Takeda’s new narcolepsy type 1 drug also became available in China and Japan, giving patients access to a first-in-class orexin treatment. Care Closer to Home: China is expanding community healthcare and rehabilitation services as it advances its Healthy China initiative, with a growing need for care suited to an ageing population. Global Health: China is highlighting its international health partnerships, including a Chinese medical team’s aid work in Sierra Leone. Nutrition Research: A study of more than 170,000 people in China and the UK linked frequent garlic consumption with lower odds of several chronic diseases; the findings show an association, not proof that garlic prevents illness.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.